|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
22,500 |
42,500
(0%)
|
0%
|
|
-
|
Common Stock |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
200,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
10,230 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
20,460 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
|
03 Feb 2026 |
42,500 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
200,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
22,500 |
42,500
(0%)
|
0%
|
|
-
|
Common Stock |
|
Stacy J. Kanter
|
Director |
|
03 Feb 2026 |
42,500 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
20,460 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
10,230 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
20,460 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
22,500 |
82,922
(0%)
|
0%
|
|
-
|
Common Stock |
|
Teena Lerner
|
Director |
|
03 Feb 2026 |
82,922 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
23,941 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
200,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 Feb 2026 |
10,230 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Funtleyder Les
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Jan 2026 |
150,000 |
1,340,459
(7%)
|
0%
|
|
0
|
Common Stock |
|
Corwin Dale Hooks
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2025 |
312,500 |
868,253
(4%)
|
1%
|
|
0
|
Common Stock |
|
Corwin Dale Hooks
|
Chief Commercial Officer |
|
19 Dec 2025 |
5,753 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Corwin Dale Hooks
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
862,500 |
5,753
(0%)
|
4%
|
|
-
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2025 |
1,187,500 |
2,527,959
(13%)
|
6%
|
|
0
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
2,375,000 |
152,959
(0%)
|
12%
|
|
-
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
|
19 Dec 2025 |
152,959 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
20,460 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
10,230 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
16,500 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
150,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
40,502 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Constantine Chinoporos
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2025 |
437,500 |
1,057,111
(5%)
|
2%
|
|
0
|
Common Stock |
|
Constantine Chinoporos
|
See Remarks |
|
19 Dec 2025 |
57,111 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Constantine Chinoporos
|
See Remarks |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
1,000,000 |
57,111
(0%)
|
5%
|
|
-
|
Common Stock |
|
Evan Prescott Bailey
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2025 |
437,500 |
1,296,816
(6%)
|
2%
|
|
0
|
Common Stock |
|
Evan Prescott Bailey
|
Chief Medical Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
19,531 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Evan Prescott Bailey
|
Chief Medical Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
4,883 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Evan Prescott Bailey
|
Chief Medical Officer |
|
19 Dec 2025 |
60,901 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
|
Evan Prescott Bailey
|
Chief Medical Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Dec 2025 |
1,235,915 |
60,901
(0%)
|
6%
|
|
-
|
Common Stock |
|
Stacy J. Kanter
|
Director |
Sale of securities on an exchange or to another person at price $ 0.11 per share. |
16 Dec 2025 |
43,000 |
65,000
(0%)
|
0%
|
0.1 |
4,816
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Oct 2025 |
150,000 |
1,190,459
(6%)
|
0%
|
|
0
|
Common Stock |
|
Evan Prescott Bailey
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2025 |
300,000 |
841,669
(4%)
|
1%
|
|
0
|
Common Stock |
|
Jay S. Skyler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2025 |
200,000 |
200,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2025 |
200,000 |
200,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2025 |
200,000 |
200,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2025 |
150,000 |
787,121
(4%)
|
0%
|
|
0
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2025 |
150,000 |
937,121
(5%)
|
0%
|
|
0
|
Common Stock |
|
Corwin Dale Hooks
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Mar 2025 |
250,000 |
550,000
(2%)
|
1%
|
|
0
|
Common Stock |
|
Les Funtleyder
|
Director, See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Mar 2025 |
350,000 |
740,459
(3%)
|
1%
|
|
0
|
Common Stock |
|
Constantine Chinoporos
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Mar 2025 |
350,000 |
621,436
(3%)
|
1%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.44 per share. |
04 Mar 2025 |
10,366 |
890,409
(4%)
|
0%
|
0.4 |
4,561
|
Common Stock |
|
Les Funtleyder
|
Director, See Remarks |
Sale of securities on an exchange or to another person at price $ 0.44 per share. |
04 Mar 2025 |
14,502 |
390,459
(2%)
|
0%
|
0.4 |
6,381
|
Common Stock |
|
Constantine Chinoporos
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 0.44 per share. |
04 Mar 2025 |
447 |
271,436
(1%)
|
0%
|
0.4 |
197
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 0.61 per share. |
06 Feb 2025 |
86,078 |
900,775
(4%)
|
0%
|
0.6 |
52,508
|
Common Stock |
|
Les Funtleyder
|
Director, See Remarks |
Sale of securities on an exchange or to another person at price $ 0.61 per share. |
06 Feb 2025 |
22,950 |
404,961
(2%)
|
0%
|
0.6 |
14,000
|
Common Stock |
|
Constantine Chinoporos
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 0.61 per share. |
06 Feb 2025 |
28,117 |
271,883
(1%)
|
0%
|
0.6 |
17,151
|
Common Stock |
|
Les Funtleyder
|
Director, See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2024 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Funtleyder Les
|
Director, See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Dec 2024 |
150,000 |
427,911
(2%)
|
0%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
22 Aug 2024 |
22,681 |
986,853
(5%)
|
0%
|
5.8 |
132,230
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 5.83 per share. |
22 Aug 2024 |
13,530 |
277,911
(1%)
|
0%
|
5.8 |
78,880
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
05 Aug 2024 |
747,886 |
747,886
(4%)
|
4%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
05 Aug 2024 |
747,886 |
0
(0%)
|
4%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 5.93 per share. |
05 Aug 2024 |
119,591 |
4,690,839
(25%)
|
0%
|
5.9 |
709,175
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 6.18 per share. |
05 Aug 2024 |
357,423 |
4,810,430
(25%)
|
1%
|
6.2 |
2,208,874
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO |
Sale of securities on an exchange or to another person at price $ 5.98 per share. |
05 Aug 2024 |
300,000 |
5,167,853
(27%)
|
1%
|
6.0 |
1,794,000
|
Common Stock |
|
Jay S. Skyler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
45,000 |
65,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joel S. Marcus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
45,000 |
498,414
(2%)
|
0%
|
|
0
|
Common Stock |
|
Stacy J. Kanter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
45,000 |
108,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Teena Lerner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2024 |
45,000 |
105,422
(0%)
|
0%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 4.32 per share. |
06 Jun 2024 |
61,795 |
3,756,019
(20%)
|
0%
|
4.3 |
266,954
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jun 2024 |
22,003 |
1,009,534
(5%)
|
0%
|
4.3 |
95,053
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 4.32 per share. |
06 Jun 2024 |
16,980 |
291,441
(1%)
|
0%
|
4.3 |
73,354
|
Common Stock |
|
Corwin Dale Hooks
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Apr 2024 |
300,000 |
300,000
(1%)
|
1%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 5.39 per share. |
14 Mar 2024 |
318,573 |
3,817,814
(20%)
|
1%
|
5.4 |
1,717,108
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
14 Mar 2024 |
110,804 |
1,031,537
(5%)
|
0%
|
5.4 |
597,234
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 5.39 per share. |
14 Mar 2024 |
28,727 |
308,421
(1%)
|
0%
|
5.4 |
154,839
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 5.39 per share. |
14 Mar 2024 |
48,871 |
732,919
(3%)
|
0%
|
5.4 |
263,415
|
Common Stock |
|
Constantine Chinoporos
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Dec 2023 |
300,000 |
300,000
(1%)
|
1%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Dec 2023 |
440,000 |
4,136,387
(22%)
|
2%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
21 Dec 2023 |
450,000 |
1,142,341
(6%)
|
2%
|
|
0
|
Common Stock |
|
Shendelman Shoshana
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Dec 2023 |
1,100,000 |
3,696,387
(19%)
|
5%
|
|
0
|
Common Stock |
|
Hansard Adam
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Dec 2023 |
400,000 |
781,790
(4%)
|
2%
|
|
0
|
Common Stock |
|
Kanter Stacy J.
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.18 per share. |
01 Dec 2023 |
30,000 |
63,000
(0%)
|
0%
|
2.2 |
65,367
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 1.97 per share. |
30 Nov 2023 |
3,968 |
2,596,387
(14%)
|
0%
|
2.0 |
7,817
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 1.97 per share. |
30 Nov 2023 |
965 |
381,790
(2%)
|
0%
|
2.0 |
1,901
|
Common Stock |
|
Les Funtleyder
|
Director, Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Nov 2023 |
300,000 |
337,148
(1%)
|
1%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 2.70 per share. |
27 Sep 2023 |
115,632 |
2,600,355
(14%)
|
0%
|
2.7 |
312,206
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Sep 2023 |
10,932 |
693,924
(3%)
|
0%
|
2.7 |
29,516
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 2.70 per share. |
27 Sep 2023 |
9,720 |
382,755
(2%)
|
0%
|
2.7 |
26,244
|
Common Stock |
|
Joel S. Marcus
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Sep 2023 |
12,375 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. |
15 Sep 2023 |
12,375 |
453,414
(2%)
|
0%
|
1.1 |
12,994
|
Common Stock |
|
Jay S. Skyler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2023 |
20,000 |
20,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Joel S. Marcus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2023 |
20,000 |
441,039
(2%)
|
0%
|
|
0
|
Common Stock |
|
Les Funtleyder
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2023 |
20,000 |
37,148
(0%)
|
0%
|
|
0
|
Common Stock |
|
Stacy J. Kanter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2023 |
20,000 |
33,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Teena Lerner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
06 Jun 2023 |
20,000 |
60,422
(0%)
|
0%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 0.91 per share. |
11 Jan 2023 |
15,870 |
751,625
(4%)
|
0%
|
0.9 |
14,442
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2023 |
1,964,362 |
2,715,987
(14%)
|
10%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Jan 2023 |
550,000 |
704,856
(3%)
|
2%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Jan 2023 |
6,053 |
154,856
(0%)
|
0%
|
0.9 |
5,508
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jan 2023 |
300,000 |
392,475
(2%)
|
1%
|
|
0
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 0.91 per share. |
11 Jan 2023 |
4,495 |
92,475
(0%)
|
0%
|
0.9 |
4,090
|
Common Stock |
|
Steven Ortega
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Nov 2022 |
40,000 |
55,404
(0%)
|
0%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.64 per share. |
14 Oct 2022 |
50,000 |
767,495
(4%)
|
0%
|
0.6 |
32,250
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.56 per share. |
13 Oct 2022 |
73,256 |
717,495
(3%)
|
0%
|
0.6 |
40,891
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.52 per share. |
12 Oct 2022 |
38,153 |
644,239
(3%)
|
0%
|
0.5 |
19,943
|
Common Stock |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
20,460
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
10,230
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
7,389 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
10,230
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
7,389 |
7,389
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
8,824 |
8,824
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
8,824 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
7,264 |
7,264
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
7,264 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
19,058 |
19,058
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
19,058 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
23,317 |
23,317
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
234,616 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
234,616 |
234,616
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
101,670 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
101,670 |
101,670
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
134,979 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
134,979 |
134,979
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
23,317 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
607,484 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
607,484 |
607,484
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
36,495 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
134,997 |
134,997
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
50,000 |
50,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
32,100 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
32,100 |
32,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
32,100 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
32,100 |
32,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
134,997 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
51,666 |
51,666
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
51,666 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
02 Aug 2022 |
36,495 |
36,495
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
20,460
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
10,230
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
10,230
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
20,460
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
20,460
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
20,460 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
10,230
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
10,230 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
16,500 |
16,500
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
32,339 |
32,339
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
50,000 |
50,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
21,100 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
21,100 |
21,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
21,100 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
21,100 |
21,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
32,339 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
104,665 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
02 Aug 2022 |
104,665 |
104,665
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Jay S. Skyler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2022 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2022 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2022 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2022 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2022 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Sale of securities on an exchange or to another person at price $ 1.65 per share. |
16 May 2022 |
905 |
9,800
(0%)
|
0%
|
1.6 |
1,493
|
Common Stock |
|
Chids Mahadevan
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Apr 2022 |
19,058 |
19,058
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Chids Mahadevan
|
See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Apr 2022 |
2,136 |
10,705
(0%)
|
0%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Apr 2022 |
50,000 |
50,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Apr 2022 |
50,000 |
50,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Steven Ortega
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Apr 2022 |
10,675 |
10,675
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Steven Ortega
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Apr 2022 |
3,081 |
15,404
(0%)
|
0%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
21 Mar 2022 |
12,548 |
108,948
(0%)
|
0%
|
1.9 |
23,214
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
21 Mar 2022 |
30,000 |
160,909
(0%)
|
0%
|
2.0 |
59,100
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
21 Mar 2022 |
21,961 |
130,909
(0%)
|
0%
|
2.0 |
43,483
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Jan 2022 |
234,616 |
234,616
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2022 |
120,900 |
606,086
(3%)
|
0%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2022 |
80,600 |
80,600
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Jan 2022 |
32,100 |
32,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Jan 2022 |
48,200 |
96,400
(0%)
|
0%
|
|
0
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2022 |
21,100 |
21,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2022 |
31,700 |
96,970
(0%)
|
0%
|
|
0
|
Common Stock |
|
Charles Silberstein
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2022 |
32,000 |
32,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Charles Silberstein
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2022 |
47,900 |
183,603
(0%)
|
0%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
120,900 |
485,186
(2%)
|
0%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
80,600 |
80,600
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
32,100 |
32,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
48,200 |
48,200
(0%)
|
0%
|
|
0
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
21,100 |
21,100
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
31,700 |
65,270
(0%)
|
0%
|
|
0
|
Common Stock |
|
Charles Silberstein
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
32,000 |
32,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Charles Silberstein
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Dec 2021 |
47,900 |
135,703
(0%)
|
0%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 14.49 per share. |
13 Sep 2021 |
9,300 |
364,286
(1%)
|
0%
|
14.5 |
134,740
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 14.69 per share. |
13 Sep 2021 |
701 |
354,986
(1%)
|
0%
|
14.7 |
10,298
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
10,300 |
4,700
(0%)
|
0%
|
17.2 |
176,954
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
8,873 |
94,874
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
15,000 |
103,747
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
800 |
0
(0%)
|
0%
|
16.4 |
13,080
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
8,273 |
600
(0%)
|
0%
|
15.8 |
131,127
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
8,873 |
8,873
(0%)
|
0%
|
1.4 |
12,777
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
4,700 |
0
(0%)
|
0%
|
17.9 |
83,895
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
09 Aug 2021 |
15,000 |
15,000
(0%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
7,224 |
0
(0%)
|
0%
|
17.4 |
125,625
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
118,747
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
133,747
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
148,747
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
0
(0%)
|
0%
|
17.2 |
257,700
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
15,000
(0%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
0
(0%)
|
0%
|
17.5 |
262,500
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
15,000
(0%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
7,776 |
7,224
(0%)
|
0%
|
17.1 |
132,581
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Jul 2021 |
15,000 |
15,000
(0%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
164,667
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
0
(0%)
|
0%
|
19.5 |
8,988
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
0
(0%)
|
0%
|
20.5 |
9,435
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
0
(0%)
|
0%
|
21.3 |
9,775
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
163,747
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
13 Jul 2021 |
460 |
164,207
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
1,200 |
0
(0%)
|
0%
|
24.0 |
28,812
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
1,987 |
1,200
(0%)
|
0%
|
23.5 |
46,714
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
360 |
3,187
(0%)
|
0%
|
22.0 |
7,906
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
3,547 |
3,547
(0%)
|
0%
|
1.4 |
5,108
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
460 |
165,127
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
460 |
165,587
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
3,547 |
166,047
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
300 |
0
(0%)
|
0%
|
21.7 |
6,513
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
160 |
300
(0%)
|
0%
|
20.8 |
3,328
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
460 |
0
(0%)
|
0%
|
21.8 |
10,010
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Jun 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Charles Silberstein
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 21.42 per share. |
08 Jun 2021 |
5,047 |
87,803
(0%)
|
0%
|
21.4 |
108,107
|
Common Stock |
|
Jay S. Skyler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2021 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2021 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
170,054
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
170,514
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
260 |
0
(0%)
|
0%
|
21.4 |
5,559
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
200 |
260
(0%)
|
0%
|
20.4 |
4,086
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
0
(0%)
|
0%
|
19.7 |
9,039
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
0
(0%)
|
0%
|
19.7 |
9,044
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
169,594
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
03 Jun 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Les Funtleyder
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2021 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2021 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Jun 2021 |
16,500 |
16,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 18.35 per share. |
26 May 2021 |
2,894 |
33,570
(0%)
|
0%
|
18.4 |
53,105
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
1,640 |
171,894
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
460 |
0
(0%)
|
0%
|
19.4 |
8,938
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
460 |
0
(0%)
|
0%
|
18.0 |
8,266
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
1,640 |
1,640
(0%)
|
0%
|
1.4 |
2,362
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
1,640 |
0
(0%)
|
0%
|
17.3 |
28,290
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
460 |
170,974
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
24 May 2021 |
460 |
171,434
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 May 2021 |
200 |
0
(0%)
|
0%
|
17.3 |
3,454
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 May 2021 |
200 |
173,534
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 May 2021 |
200 |
200
(0%)
|
0%
|
1.4 |
288
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
465 |
0
(0%)
|
0%
|
19.7 |
9,151
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
460 |
176,494
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
465 |
176,954
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
465 |
177,419
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
460 |
0
(0%)
|
0%
|
18.4 |
8,478
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
460 |
460
(0%)
|
0%
|
1.4 |
662
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
465 |
0
(0%)
|
0%
|
18.5 |
8,616
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
26 Mar 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
0
(0%)
|
0%
|
18.5 |
8,593
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
177,884
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
178,349
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
178,814
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
0
(0%)
|
0%
|
19.6 |
9,119
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
0
(0%)
|
0%
|
19.4 |
9,012
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
11 Mar 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
1,295 |
1,295
(0%)
|
0%
|
1.4 |
1,865
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
1,295 |
179,279
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
2,125 |
180,574
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
465 |
182,669
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
1,295 |
0
(0%)
|
0%
|
23.2 |
30,044
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
600 |
0
(0%)
|
0%
|
24.6 |
14,742
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
1,525 |
600
(0%)
|
0%
|
23.7 |
36,158
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
2,125 |
2,125
(0%)
|
0%
|
1.4 |
3,060
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
465 |
0
(0%)
|
0%
|
21.8 |
10,156
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
23 Feb 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Stacy J. Kanter
|
Director |
Purchase of securities on an exchange or from another person at price $ 22.86 per share. |
19 Feb 2021 |
6,500 |
13,000
(0%)
|
0%
|
22.9 |
148,590
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
1,295 |
183,164
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
1,295 |
184,459
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
3,785 |
185,754
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
600 |
0
(0%)
|
0%
|
27.3 |
16,380
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
695 |
600
(0%)
|
0%
|
26.3 |
18,313
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
1,295 |
1,295
(0%)
|
0%
|
1.4 |
1,865
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
595 |
0
(0%)
|
0%
|
27.8 |
16,523
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
700 |
595
(0%)
|
0%
|
26.9 |
18,809
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
1,295 |
1,295
(0%)
|
0%
|
1.4 |
1,865
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
660 |
0
(0%)
|
0%
|
26.4 |
17,444
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
2,325 |
660
(0%)
|
0%
|
25.5 |
59,218
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
3,785 |
3,785
(0%)
|
0%
|
1.4 |
5,450
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
01 Feb 2021 |
800 |
2,985
(0%)
|
0%
|
24.4 |
19,488
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
0
(0%)
|
0%
|
21.8 |
10,151
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
189,539
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
189,004
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
189,469
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
0
(0%)
|
0%
|
20.3 |
9,440
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
0
(0%)
|
0%
|
21.1 |
9,802
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
19 Jan 2021 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
7,600 |
0
(0%)
|
0%
|
23.5 |
178,600
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
7,985 |
189,934
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
765 |
197,919
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
7,765 |
198,684
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
7,685 |
0
(0%)
|
0%
|
23.2 |
178,138
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
300 |
7,685
(0%)
|
0%
|
21.9 |
6,576
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
7,765 |
7,765
(0%)
|
0%
|
1.4 |
11,182
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
7,985 |
7,985
(0%)
|
0%
|
1.4 |
11,498
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
765 |
0
(0%)
|
0%
|
21.9 |
16,738
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
765 |
765
(0%)
|
0%
|
1.4 |
1,102
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
06 Jan 2021 |
165 |
7,600
(0%)
|
0%
|
22.2 |
3,658
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
206,449
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
206,914
|
-
|
|
-
|
Stock Option (Right to Buy |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
207,379
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
65 |
0
(0%)
|
0%
|
21.7 |
1,409
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
400 |
65
(0%)
|
0%
|
21.0 |
8,388
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
0
(0%)
|
0%
|
22.0 |
10,207
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
28 Dec 2020 |
465 |
0
(0%)
|
0%
|
21.8 |
10,142
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Dec 2020 |
256,850 |
256,850
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
10 Dec 2020 |
92,200 |
92,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Dec 2020 |
81,700 |
81,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles Silberstein
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
10 Dec 2020 |
92,850 |
92,850
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
0
(0%)
|
0%
|
20.5 |
9,528
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
207,844
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
208,309
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
208,774
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
0
(0%)
|
0%
|
20.5 |
9,514
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
0
(0%)
|
0%
|
20.0 |
9,291
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
07 Dec 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
900 |
760
(0%)
|
0%
|
18.7 |
16,812
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
465 |
209,239
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
465 |
209,704
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
1,660 |
210,169
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
465 |
0
(0%)
|
0%
|
21.6 |
10,053
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
465 |
0
(0%)
|
0%
|
20.6 |
9,574
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
760 |
0
(0%)
|
0%
|
19.5 |
14,850
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
20 Nov 2020 |
1,660 |
1,660
(0%)
|
0%
|
1.4 |
2,390
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
10 Nov 2020 |
200 |
0
(0%)
|
0%
|
17.6 |
3,518
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
10 Nov 2020 |
200 |
211,829
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
10 Nov 2020 |
200 |
200
(0%)
|
0%
|
1.4 |
288
|
Common Stock |
|
Joel S. Marcus
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Oct 2020 |
50,000 |
315,360
(1%)
|
0%
|
|
0
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
212,029
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
212,494
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
212,959
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
0
(0%)
|
0%
|
17.3 |
8,031
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
0
(0%)
|
0%
|
18.5 |
8,598
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
0
(0%)
|
0%
|
21.2 |
9,858
|
Common Stock |
|
Riccardo Perfetti
|
Chief Medical Officer |
|
27 Oct 2020 |
465 |
465
(0%)
|
0%
|
1.4 |
670
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2020 |
30,000 |
40,502
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 20.07 per share. |
01 Oct 2020 |
5,976 |
17,148
(0%)
|
0%
|
20.1 |
119,938
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 20.75 per share. |
01 Oct 2020 |
1,353 |
23,124
(0%)
|
0%
|
20.8 |
28,075
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 20.03 per share. |
01 Oct 2020 |
22,671 |
24,477
(0%)
|
0%
|
20.0 |
454,100
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. |
01 Oct 2020 |
30,000 |
47,148
(0%)
|
0%
|
4.7 |
141,000
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Aug 2020 |
20,000 |
70,502
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 24.18 per share. |
21 Aug 2020 |
6,461 |
17,148
(0%)
|
0%
|
24.2 |
156,227
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 23.42 per share. |
21 Aug 2020 |
13,539 |
23,609
(0%)
|
0%
|
23.4 |
317,083
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. |
21 Aug 2020 |
20,000 |
37,148
(0%)
|
0%
|
4.7 |
94,000
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. |
20 Jul 2020 |
15,000 |
569,285
(3%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 27.19 per share. |
20 Jul 2020 |
12,100 |
557,185
(3%)
|
0%
|
27.2 |
328,999
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jul 2020 |
15,000 |
539,609
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jul 2020 |
15,000 |
554,609
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Jul 2020 |
15,000 |
569,609
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 26.51 per share. |
20 Jul 2020 |
2,949 |
554,285
(2%)
|
0%
|
26.5 |
78,178
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 25.45 per share. |
20 Jul 2020 |
12,051 |
557,235
(3%)
|
0%
|
25.5 |
306,698
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. |
20 Jul 2020 |
15,000 |
569,285
(3%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 28.24 per share. |
20 Jul 2020 |
100 |
554,285
(2%)
|
0%
|
28.2 |
2,824
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 27.42 per share. |
20 Jul 2020 |
7,300 |
554,385
(2%)
|
0%
|
27.4 |
200,166
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 26.69 per share. |
20 Jul 2020 |
7,600 |
561,685
(3%)
|
0%
|
26.7 |
202,844
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. |
20 Jul 2020 |
15,000 |
569,285
(3%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 28.64 per share. |
20 Jul 2020 |
300 |
554,285
(2%)
|
0%
|
28.6 |
8,592
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 27.88 per share. |
20 Jul 2020 |
2,600 |
554,585
(2%)
|
0%
|
27.9 |
72,488
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. |
07 Jul 2020 |
15,000 |
569,285
(3%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. |
07 Jul 2020 |
15,000 |
569,285
(3%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 31.63 per share. |
07 Jul 2020 |
1,995 |
567,290
(3%)
|
0%
|
31.6 |
63,102
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 32.25 per share. |
07 Jul 2020 |
13,005 |
554,285
(2%)
|
0%
|
32.2 |
419,411
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. |
07 Jul 2020 |
15,000 |
569,285
(3%)
|
0%
|
1.4 |
21,600
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 32.21 per share. |
07 Jul 2020 |
12,889 |
556,396
(3%)
|
0%
|
32.2 |
415,155
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 32.98 per share. |
07 Jul 2020 |
2,111 |
554,285
(2%)
|
0%
|
33.0 |
69,621
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 30.90 per share. |
07 Jul 2020 |
10,936 |
558,349
(3%)
|
0%
|
30.9 |
337,922
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 31.64 per share. |
07 Jul 2020 |
4,064 |
554,285
(2%)
|
0%
|
31.6 |
128,585
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jul 2020 |
15,000 |
614,605
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jul 2020 |
15,000 |
599,605
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jul 2020 |
15,000 |
584,605
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 43.32 per share. |
23 Jun 2020 |
4,629 |
32,519
(0%)
|
0%
|
43.3 |
200,528
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 38.28 per share. |
23 Jun 2020 |
100 |
17,148
(0%)
|
0%
|
38.3 |
3,828
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 37.52 per share. |
23 Jun 2020 |
517 |
17,248
(0%)
|
0%
|
37.5 |
19,398
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 36.12 per share. |
23 Jun 2020 |
200 |
17,765
(0%)
|
0%
|
36.1 |
7,224
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 40.92 per share. |
23 Jun 2020 |
400 |
17,965
(0%)
|
0%
|
40.9 |
16,368
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 40.41 per share. |
23 Jun 2020 |
3,811 |
18,365
(0%)
|
0%
|
40.4 |
154,003
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 39.20 per share. |
23 Jun 2020 |
3,572 |
22,176
(0%)
|
0%
|
39.2 |
140,022
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 47.40 per share. |
23 Jun 2020 |
1,340 |
25,748
(0%)
|
0%
|
47.4 |
63,516
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 46.45 per share. |
23 Jun 2020 |
160 |
27,088
(0%)
|
0%
|
46.5 |
7,432
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 45.35 per share. |
23 Jun 2020 |
1,809 |
27,248
(0%)
|
0%
|
45.3 |
82,038
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.54 per share. |
23 Jun 2020 |
3,462 |
29,057
(0%)
|
0%
|
44.5 |
154,197
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 45.91 per share. |
18 Jun 2020 |
11 |
17,148
(0%)
|
0%
|
45.9 |
505
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Jun 2020 |
20,000 |
90,502
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. |
18 Jun 2020 |
20,000 |
37,148
(0%)
|
0%
|
4.7 |
94,000
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 45.32 per share. |
18 Jun 2020 |
7,487 |
17,159
(0%)
|
0%
|
45.3 |
339,311
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.37 per share. |
15 Jun 2020 |
5,302 |
28,846
(0%)
|
0%
|
44.4 |
235,250
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2020 |
17,000 |
110,502
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.15 per share. |
15 Jun 2020 |
4,100 |
24,646
(0%)
|
0%
|
44.2 |
181,015
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 45.18 per share. |
15 Jun 2020 |
100 |
28,746
(0%)
|
0%
|
45.2 |
4,518
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. |
15 Jun 2020 |
17,000 |
34,148
(0%)
|
0%
|
4.7 |
79,900
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.77 per share. |
08 Jun 2020 |
8,315 |
25,833
(0%)
|
0%
|
44.8 |
372,263
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jun 2020 |
17,000 |
127,502
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 42.83 per share. |
08 Jun 2020 |
2,563 |
17,148
(0%)
|
0%
|
42.8 |
109,773
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 41.80 per share. |
08 Jun 2020 |
2,622 |
19,711
(0%)
|
0%
|
41.8 |
109,600
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.87 per share. |
08 Jun 2020 |
1,500 |
22,333
(0%)
|
0%
|
44.9 |
67,305
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 42.82 per share. |
08 Jun 2020 |
2,000 |
23,833
(0%)
|
0%
|
42.8 |
85,640
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. |
08 Jun 2020 |
17,000 |
34,148
(0%)
|
0%
|
4.7 |
79,900
|
Common Stock |
|
Jay S. Skyler
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
10,230 |
10,230
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Joel S. Marcus
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
10,230 |
10,230
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Stacy J. Kanter
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
10,230 |
10,230
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Teena Lerner
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
10,230 |
10,230
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Charles Silberstein
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
183,000 |
183,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
|
Charles Silberstein
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Jun 2020 |
61,000 |
61,000
(0%)
|
0%
|
|
0
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. |
02 Jun 2020 |
15,000 |
32,148
(0%)
|
0%
|
4.7 |
70,500
|
Common Stock |
|
Les Funtleyder
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Jun 2020 |
10,230 |
10,230
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jun 2020 |
15,000 |
144,502
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.17 per share. |
02 Jun 2020 |
1,482 |
17,148
(0%)
|
0%
|
44.2 |
65,460
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.03 per share. |
02 Jun 2020 |
1,032 |
18,630
(0%)
|
0%
|
44.0 |
45,439
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 45.21 per share. |
02 Jun 2020 |
12,486 |
19,662
(0%)
|
0%
|
45.2 |
564,492
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Gift of securities by or to the insider at price $ 0.00 per share. |
28 May 2020 |
290,280 |
3,014,005
(16%)
|
1%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. |
28 May 2020 |
97,376 |
679,285
(3%)
|
0%
|
1.4 |
140,221
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. |
28 May 2020 |
27,624 |
581,909
(3%)
|
0%
|
1 |
27,624
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Gift of securities by or to the insider at price $ 0.00 per share. |
28 May 2020 |
709,720 |
709,720
(3%)
|
3%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Gift of securities by or to the insider at price $ 0.00 per share. |
28 May 2020 |
290,280 |
290,280
(1%)
|
1%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Gift of securities by or to the insider at price $ 0.00 per share. |
28 May 2020 |
709,720 |
2,304,285
(12%)
|
3%
|
|
0
|
Common Stock |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 May 2020 |
97,376 |
629,605
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 May 2020 |
27,624 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Shoshana Shendelman
|
Director, President and CEO, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 42.70 per share. |
28 May 2020 |
125,000 |
554,285
(2%)
|
0%
|
42.7 |
5,337,500
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 44.27 per share. |
28 May 2020 |
7,120 |
25,643
(0%)
|
0%
|
44.3 |
315,202
|
Common Stock |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 48.27 per share. |
28 May 2020 |
2,838 |
32,763
(0%)
|
0%
|
48.3 |
136,990
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. |
28 May 2020 |
18,453 |
35,601
(0%)
|
0%
|
0.0 |
738
|
Common Stock |
|
Les Funtleyder
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 May 2020 |
18,453 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
|
Les Funtleyder
|
Director |
Sale of securities on an exchange or to another person at price $ 45.08 per share. |
28 May 2020 |
8,495 |
17,148
(0%)
|
0%
|
45.1 |
382,955
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 47.88 per share. |
13 May 2020 |
1,600 |
384,579
(2%)
|
0%
|
47.9 |
76,608
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 45.29 per share. |
13 May 2020 |
500 |
388,191
(2%)
|
0%
|
45.3 |
22,645
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 43.60 per share. |
13 May 2020 |
10,764 |
394,596
(2%)
|
0%
|
43.6 |
469,310
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 43.69 per share. |
13 May 2020 |
100 |
365,360
(1%)
|
0%
|
43.7 |
4,369
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 43.20 per share. |
13 May 2020 |
5,723 |
365,460
(1%)
|
0%
|
43.2 |
247,234
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 43.18 per share. |
13 May 2020 |
9,177 |
371,183
(2%)
|
0%
|
43.2 |
396,263
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 49.66 per share. |
13 May 2020 |
2,017 |
380,360
(2%)
|
0%
|
49.7 |
100,164
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 48.77 per share. |
13 May 2020 |
2,202 |
382,377
(2%)
|
0%
|
48.8 |
107,392
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 44.46 per share. |
13 May 2020 |
5,905 |
388,691
(2%)
|
0%
|
44.5 |
262,536
|
Common Stock |
|
Joel S. Marcus
|
Director |
Sale of securities on an exchange or to another person at price $ 46.61 per share. |
13 May 2020 |
2,012 |
386,179
(2%)
|
0%
|
46.6 |
93,779
|
Common Stock |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2020 |
179,425 |
179,425
|
-
|
|
-
|
Employee Stock Option (right to buy) |
|
Adam Hansard
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2020 |
36,464 |
36,464
(0%)
|
0%
|
|
0
|
Common Stock |
|
Teena Lerner
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Feb 2020 |
11,970 |
23,941
|
-
|
|
-
|
Stock Option (right to buy) |
|
Teena Lerner
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. |
06 Feb 2020 |
18,453 |
37,623
(0%)
|
0%
|
1 |
18,453
|
Common Stock |